Clinical Trials Directory

Trials / Completed

CompletedNCT00527462

Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles on Airway Inflammation in Asthmatics

Mono-Center, Double-Blind, Cross-Over Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles Versus Filtered Air on Airway Inflammation Induced by Segmental Allergen Challenge in Asthmatics

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Fraunhofer-Institute of Toxicology and Experimental Medicine · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to test the hypothesis that the allergic airway inflammation in asthmatic patients will be enhanced after exposure to ultrafine particles (UFP). In order to test this in a controlled study, the researchers combine controlled exposure to carbon black model UFP with the well-established model of a segmental allergen challenge, which allows the researchers to safely induce circumscript allergic inflammation in the lung in mild asthmatics. The effect of the UFP on allergic inflammation will be controlled by an inhalation of clean air in a randomized, double-blind, crossover design.

Conditions

Interventions

TypeNameDescription
PROCEDUREBronchoscopybronchoscopy with segmental allergen challenge
OTHERExposure to ultrafine carbon black particlesExposure to ultrafine carbon black particles for 2 hours

Timeline

Start date
2007-09-01
Primary completion
2008-04-01
Completion
2008-04-01
First posted
2007-09-11
Last updated
2008-04-30

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00527462. Inclusion in this directory is not an endorsement.